MARLBOROUGH, Mass. / Oct 02, 2025 / Business Wire / Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the fourth quarter of fiscal 2025 on Monday, November 3, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.
Interested participants may listen to the call by dialing 800-330-6710 (in the United States and Canada) or +1 312-471-1353 (for international callers) and referencing access code 5756948. Participants may also click here to join. Participants should dial in 5-10 minutes before the call begins.
Hologic will provide a live and webcast replay of the call on the Company’s website at investors.hologic.com. The call will be available there for 30 days. The webcast replay will be available approximately two hours after the call ends.
About Hologic
Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.
| Last Trade: | US$74.80 |
| Daily Volume: | 0 |
| Market Cap: | US$16.670B |
November 25, 2025 November 03, 2025 October 21, 2025 October 02, 2025 | |

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREEnd of content
No more pages to load